A little while ago I tumbled into an AI-research rabbit hole on storage requirements for different peptides, and what surprised me was how fragile many of these compounds turn out to be. It applies most obviously to a few of the ones people report wildly different outcomes with, MOTS-C and NAD+ among them, to the point where I now wonder whether storage and drawing technique account for a large share of that spread. There's a good chance plenty of people have been injecting doses that had already degraded significantly; had I not come across this material, and had I drawn everything the way I draw Reta, I'd likely have thrown away most or all of the potency on the others. Here's the summary:
- MOTS-C, NAD+, HGH and AOD 9064 are all EXTREMELY sensitive to light and temperature, and degradation starts almost the moment they leave the fridge. The profile is cumulative: every minute spent above 46 degrees Fahrenheit eats into their lifespan, the losses stack up across repeated draws, and putting them back in the fridge does not reset anything. They are fragile enough that the recommended approach avoided leaving them out on a sink counter under light even for a draw; keep them in the case until the very last second and put them on a chilled surface if they come out of the box. The moment a dose has been drawn from a vial, the suggestion was to get that vial straight back into the fridge, even before the injection site is prepped or the shot given. Holding the vial by its plastic cap or top rim was also advised, rather than gripping the body and warming it with body temp. The same was said to hold, to a slightly lesser degree, for DSIP and Sermorelin.
- MOTS-C, NAD+, HGH, AOD 9064, SS-31 and Tesamorelin are all listed as mandatory passive-draws, because of the various ways introducing oxygen can harm them. By passive draw it meant you should NOT pull air into the syringe and push it through into the vial; instead let the slower vacuum do the work of drawing the dose. That sits slightly awkwardly with the group above, where getting them back into refrigeration quickly is everything, but the extra seconds a passive draw costs were still called necessary for these. GHK-CU, CJC-1295, GHRP-2, LL-37 and Sermorelin also get the passive-draw recommendation, since they are prone to foaming that degrades potency over 2-4 weeks, though without the immediate damage the others suffer.
- MOTS-C, NAD+, HGH, AOD 9064 and Tesamorelin are all EXTREMELY vibration sensitive, to the point that flicking or even tapping the syringe to clear bubbles after a draw was advised against entirely. CJC-1295 and Sermorelin were flagged as sensitive too, though to a lesser degree: no repeated or aggressive flicking.
Luckily most of these aren't things I've started, because I've been taking NONE of these precautions lol. Beyond the slow potency loss from not passive-drawing my own GHRP-2 and Sermorelin, there hasn't been much opportunity for me to lose anything. Curious whether anyone whose results with the others fell short reckons their drawing or storage process might explain it? Anecdotal, obviously, but it would still be interesting to hear whether anybody who was disappointed by one of the more fragile ones tried again following these recommendations and came away with a different story.
- MOTS-C, NAD+, HGH and AOD 9064 are all EXTREMELY sensitive to light and temperature, and degradation starts almost the moment they leave the fridge. The profile is cumulative: every minute spent above 46 degrees Fahrenheit eats into their lifespan, the losses stack up across repeated draws, and putting them back in the fridge does not reset anything. They are fragile enough that the recommended approach avoided leaving them out on a sink counter under light even for a draw; keep them in the case until the very last second and put them on a chilled surface if they come out of the box. The moment a dose has been drawn from a vial, the suggestion was to get that vial straight back into the fridge, even before the injection site is prepped or the shot given. Holding the vial by its plastic cap or top rim was also advised, rather than gripping the body and warming it with body temp. The same was said to hold, to a slightly lesser degree, for DSIP and Sermorelin.
- MOTS-C, NAD+, HGH, AOD 9064, SS-31 and Tesamorelin are all listed as mandatory passive-draws, because of the various ways introducing oxygen can harm them. By passive draw it meant you should NOT pull air into the syringe and push it through into the vial; instead let the slower vacuum do the work of drawing the dose. That sits slightly awkwardly with the group above, where getting them back into refrigeration quickly is everything, but the extra seconds a passive draw costs were still called necessary for these. GHK-CU, CJC-1295, GHRP-2, LL-37 and Sermorelin also get the passive-draw recommendation, since they are prone to foaming that degrades potency over 2-4 weeks, though without the immediate damage the others suffer.
- MOTS-C, NAD+, HGH, AOD 9064 and Tesamorelin are all EXTREMELY vibration sensitive, to the point that flicking or even tapping the syringe to clear bubbles after a draw was advised against entirely. CJC-1295 and Sermorelin were flagged as sensitive too, though to a lesser degree: no repeated or aggressive flicking.
Luckily most of these aren't things I've started, because I've been taking NONE of these precautions lol. Beyond the slow potency loss from not passive-drawing my own GHRP-2 and Sermorelin, there hasn't been much opportunity for me to lose anything. Curious whether anyone whose results with the others fell short reckons their drawing or storage process might explain it? Anecdotal, obviously, but it would still be interesting to hear whether anybody who was disappointed by one of the more fragile ones tried again following these recommendations and came away with a different story.
